Skip to content

Zaid Ahmad Salem Alwarawrah, M.B.B.S

NPI 1255026282ActiveIndividual· Internal Medicine, Pulmonary Disease· Omaha, NE

Internal Medicine, Pulmonary Disease (M.B.B.S) in Omaha, Nebraska, licensed in NE, with an NPI issued in April 2023. Part D covered 120 prescriptions written in 2024, 80% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 2 companies reporting payments in 2025, $146.14 in all, mostly food and beverage.

Overview

NPI1255026282
StatusActive
Entity typeIndividual
CredentialM.B.B.S
Sole proprietorNo
NPI issuedApr 6, 2023
Last updated in NPPESJun 21, 2026
Certified by providerJun 21, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Pulmonary Disease Primary207RP1001X37326NE

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Pulmonary Disease (NE)

Part D prescriptions in 2024

Prescriptions (claims)120 · 135 30-day fills
Patients67
Total drug cost$12,785
Generic share80% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$146.14 · 2 payments from 2 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$146.14 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other pulmonologists in Omaha

All 69 pulmonologists in Omaha · All pulmonologists in Nebraska